UBS Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.6M Sell
238,621
-53,388
-18% -$15.9M 0.01% 1389
2025
Q4
$96.4M Buy
292,009
+10,540
+4% +$3.57M 0.02% 1042
2025
Q3
$97.2M Sell
281,469
-88,091
-24% -$26.6M 0.02% 1044
2025
Q2
$115M Buy
369,560
+144,501
+64% +$55.2M 0.02% 863
2025
Q1
$118M Sell
225,059
-120,198
-35% -$61.4M 0.02% 823
2024
Q4
$175M Buy
345,257
+21,200
+7% +$12M 0.03% 576
2024
Q3
$189M Buy
324,057
+69,357
+27% +$39.2M 0.04% 438
2024
Q2
$130M Sell
254,700
-34,800
-12% -$17.1M 0.03% 517
2024
Q1
$143M Sell
289,500
-138,295
-32% -$70.3M 0.04% 476
2023
Q4
$225M Buy
427,795
+56,316
+15% +$30M 0.07% 298
2023
Q3
$187M Buy
371,479
+247,979
+201% +$122M 0.06% 305
2023
Q2
$59.4M Sell
123,500
-29,500
-19% -$14.4M 0.02% 740
2023
Q1
$72.3M Buy
153,000
+23,100
+18% +$11.1M 0.03% 598
2022
Q4
$68.9M Buy
129,900
+60,500
+87% +$32M 0.03% 643
2022
Q3
$35M Buy
69,400
+4,100
+6% +$2.16M 0.02% 902
2022
Q2
$33.5M Sell
65,300
-21,100
-24% -$10.6M 0.01% 991
2022
Q1
$44.1M Sell
86,400
-34,400
-28% -$16.6M 0.01% 920
2021
Q4
$60.7M Buy
120,800
+66,952
+124% +$30.3M 0.02% 851
2021
Q3
$21M Buy
53,848
+23,100
+75% +$9.57M 0.01% 1474
2021
Q2
$12.3M Buy
30,748
+6,300
+26% +$2.51M ﹤0.01% 1855
2021
Q1
$9.1M Sell
24,448
-42,152
-63% -$14.6M ﹤0.01% 2031
2020
Q4
$23.4M Buy
66,600
+900
+1% +$302K 0.01% 1246
2020
Q3
$20.5M Buy
65,700
+25,000
+61% +$7.68M 0.01% 1156
2020
Q2
$12M Sell
40,700
-80,500
-66% -$23.1M 0.01% 1376
2020
Q1
$30.2M Sell
121,200
-4,100
-3% -$1.13M 0.01% 774
2019
Q4
$36.8M Buy
125,300
+71,700
+134% +$18.8M 0.01% 958
2019
Q3
$11.6M Sell
53,600
-18,235
-25% -$4.4M ﹤0.01% 1649
2019
Q2
$17.5M Buy
71,835
+37,235
+108% +$8.96M 0.01% 1304
2019
Q1
$8.55M Sell
34,600
-1,300
-4% -$332K ﹤0.01% 1800
2018
Q4
$8.94M Sell
35,900
-12,300
-26% -$3.25M ﹤0.01% 1660
2018
Q3
$12.8M Buy
+48,200
New +$12.5M 0.01% 1557
2018
Q2
Sell
-1,400
Closed -$300K 8264
2018
Q1
$300K Sell
1,400
-24,500
-95% -$5.6M ﹤0.01% 4518
2017
Q4
$5.71M Buy
25,900
+24,900
+2,490% +$5.28M ﹤0.01% 2231
2017
Q3
$196K Buy
+1,000
New +$193K ﹤0.01% 4862
2017
Q1
Sell
-100,200
Closed -$16M 7990
2016
Q4
$16M Sell
100,200
-67,940
-40% -$10.1M 0.01% 1169
2016
Q3
$23.5M Buy
168,140
+55,640
+49% +$7.79M 0.01% 882
2016
Q2
$15.9M Buy
+112,500
New +$15M 0.01% 1081
2016
Q1
Sell
-68,500
Closed -$8.06M 8206
2015
Q4
$8.06M Sell
68,500
-3,600
-5% -$421K 0.01% 1564
2015
Q3
$8.36M Sell
72,100
-300
-0.4% -$35.9K 0.01% 1528
2015
Q2
$8.83M Sell
72,400
-5,400
-7% -$639K 0.01% 1570
2015
Q1
$9.2M Buy
77,800
+1,800
+2% +$200K 0.01% 1543
2014
Q4
$7.68M Buy
+76,000
New +$7.2M 0.01% 1718

Other funds holding UNH

UBS Group's UNH Position: Q1 2026 in Review

UBS Group increased its UnitedHealth (UNH) stake by 27% in Q1 2026, buying an estimated $217M and bringing the position to 3,452,797 shares worth $934M. The position accounts for 0.14% of the portfolio, ranked #144.

UBS Group first reported a position in UNH in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.58B in Q3 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • UBS Group held 3,452,797 shares of UnitedHealth worth $934M as of Q1 2026.
  • UBS Group bought 729,134 UnitedHealth shares in Q1 2026, an estimated $217M.
  • UnitedHealth made up 0.14% of UBS Group's portfolio in Q1 2026, its #144 holding.
  • UBS Group first reported a position in UnitedHealth in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's UnitedHealth position peaked at $3.58B in Q3 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.